FDA Label for Dexbrompheniramine Maleate And Phenylephrine Hydrochloride
View Indications, Usage & Precautions
- OTHER
- OTC - PURPOSE
- USES
- WARNINGS
- DO NOT USE THIS PRODUCT
- ASK A DOCTOR BEFORE USE IF YOU HAVE
- OTC - ASK DOCTOR/PHARMACIST
- WHEN USING THIS PRODUCT
- STOP USE AND ASK A DOCTOR IF
- OTC - PREGNANCY OR BREAST FEEDING
- OTC - KEEP OUT OF REACH OF CHILDREN
- DIRECTIONS
- OTHER INFORMATION
- INACTIVE INGREDIENTS
- QUESTIONS? COMMENTS?
- PRINCIPAL DISPLAY PANEL - 60 TABLET BOTTLE LABEL
Dexbrompheniramine Maleate And Phenylephrine Hydrochloride Product Label
The following document was submitted to the FDA by the labeler of this product Westminster Pharmaceuticals, Llc. The document includes published materials associated whith this product with the essential scientific information about this product as well as other prescribing information. Product labels may durg indications and usage, generic names, contraindications, active ingredients, strength dosage, routes of administration, appearance, warnings, inactive ingredients, etc.
Other
DRUG FACTS
Otc - Purpose
Active ingredients (in each tablet) | Purpose |
---|---|
Dexbrompheniramine Maleate 2 mg | Antihistamine |
Phenylephrine HCL 10 mg | Nasal Decongestant |
Uses
Temporarily relieves these symptoms due to the common cold, hay fever (allergic rhinitis) or other upper respiratory allergies:
- runny nose
- sneezing
- itching of the nose or throat
- itchy, watery eyes
- nasal congestion
- reduces swelling of nasal passages
Warnings
Do not exceed recommended dosage.
Do Not Use This Product
- if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric, or emotional conditions, or Parkinson's disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product.
Ask A Doctor Before Use If You Have
- a breathing problem such as emphysema or chronic bronchitis
- glaucoma
- trouble urinating due to enlargment of the prostate gland
- heart disease
- high blood pressure
- thyroid disease
- diabetes
Otc - Ask Doctor/Pharmacist
Ask a doctor or pharmacist before use if you are taking sedatives or tranquilizers.
When Using This Product
- excitability may occur, especially in children
- may cause drowsiness
- avoid alcoholic drinks
- alcohol, sedatives, and tranquilizers may increase the drowsiness effect
- use caution when driving a motor vehicle or operating machinery
Stop Use And Ask A Doctor If
- nervousness, dizziness, or sleeplessness occur
- symptoms do not improve within 7 days or are accompanied by fever
Otc - Pregnancy Or Breast Feeding
If pregnant or breast-feeding, ask a health professional before use.
Otc - Keep Out Of Reach Of Children
Keep out of reach of children.
In case of overdose, get medical help or contact a Poison Control Center right away.
Directions
Do not exceed recommended dosage.
Adults and children 12 years of age and over: | 1 tablet every 4 to 6 hours, not to exceed 6 tablets in 24 hours or as directed by doctor. |
Children 6 to under 12 years of age: | 1/2 tablet every 4 to 6 hours, not to exceed 3 tablets in 24 hours or as directed by doctor. |
Children under 6 years of age: | Consult a doctor. |
Other Information
Store at 15°-30°C (59°-86°F). Supplied in a tight, light resistant container with a child-resistant cap. Dexbrompheniramine Maleate and Phenylephrine HCl tablets are purple, oval shaped, scored tablets, debossed "WP" bisect "197" on one side and plain on the other.
Inactive Ingredients
colloidal silicon dioxide, croscarmellose sodium, D&C Red #27, dibasic calcium phosphate dihydrate, FD&C Blue #1, magnesium stearate, and microcrystalline cellulose.
Questions? Comments?
Call 1-844-221-7294
Principal Display Panel - 60 Tablet Bottle Label
NDC 69367-197-60
Dexbrompheniramine Maleate
and Phenylephrine HCl
Antihistamine • Nasal Decongestant
Each tablet contains:
Dexbrompheniramine Maleate
2 mg
Phenylephrine HCI
10 mg
60 Tablets
Westminster
Pharmaceuticals
* Please review the disclaimer below.